Evidence map›Paper›PMID 36361738›Full record

ReviewInternational journal of molecular sciences2022

Review: Influence of 25(OH)D Blood Concentration and Supplementation during Pregnancy on Preeclampsia Development and Neonatal Outcomes.

Nataliia Karpova, Olga Dmitrenko, Ekaterina Arshinova, Malik Nurbekov

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nataliia KarpovaFederal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", Moscow 125315, Russia.ORCID 0000-0001-6391-4908
Olga DmitrenkoFederal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", Moscow 125315, Russia.
Ekaterina ArshinovaFederal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", Moscow 125315, Russia.
Malik NurbekovFederal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", Moscow 125315, Russia.
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Briefly, 25-hydroxyvitamin D (25(OH)D) plays an essential role in embryogenesis and the course of intra- and postnatal periods and is crucially involved in the functioning of the mother-placenta-fetus system. The low quantity of 25(OH)D during pregnancy can lead to an elevated risk for preeclampsia occurrence. Despite the numerous studies on the association of 25(OH)D deficiency and preeclampsia development, the current research on this theme is contradictory. In this review, we summarize and analyze study data on the effects of 25(OH)D deficiency and supplementation on pregnancy, labor, and fetal and neonatal outcomes.

Indexed as

Pre-EclampsiaPregnancy ComplicationsVitamin D DeficiencyDietary SupplementsFemaleHumansInfant, NewbornPregnancyVitamin D25-hydroxyvitamin DVitamin D1,25(OH)2D25-hydroxyvitamin D25(OH)Ddiabetesneonatal outcomepreeclampsiapregnancy complicationvitamin D deficiencyvitamin D supplementation

Identifiers

PMID36361738
PMCPMC9653937
OpenAlexW4307548387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.